|
시장보고서
상품코드
2008860
종양학 정보 시스템 시장 보고서 : 제품·서비스별, 용도별, 최종사용자별, 지역별(2026-2034년)Oncology Information Systems Market Report by Product and Services, Application, End User, and Region 2026-2034 |
||||||
세계의 종양학 정보 시스템 시장 규모는 2025년에 44억 달러에 달했습니다. 향후에 대해 IMARC Group은 2034년까지 시장 규모가 74억 달러에 달하며, 2026-2034년에 CAGR 5.71%로 성장할 것으로 예측하고 있습니다.
종양학 정보 시스템(OIS)은 생존율을 높이기 위해 암을 진단하고, 환자 프로필을 최적화하며, 적절한 치료법을 찾아낼 수 있도록 설계된 종합적인 정보 및 영상 관리 솔루션을 말합니다. 여기에는 검진, 예방, 분석, 치료 및 완화 치료가 포함됩니다. 기존 기술에 비해 종양학 시스템은 원격 액세스, 계획된 치료, 미래 예측, 임상 및 비임상 데이터에 대한 적절한 관리를 제공합니다. 이 외에도 OIS는 진단의 세부 사항과 치료 패턴의 추적을 지원하기 위해 진료소, 검사실, 병원, 연구소 등에서 널리 채택되고 있습니다.
종양학 정보 시스템 시장 동향:
종양학 정보 시스템 시장은 주로 암 발병률의 증가, 특히 고령화 인구의 증가에 의해 주도되고 있습니다. 이는 담배 제품 소비의 증가와 라이프스타일의 변화에 기인합니다. OIS는 전자건강기록(EHR)을 관리하여 환자 서비스 향상, 질병 메커니즘에 대한 새로운 지식 창출, 질병의 조기 발견, 더 나은 치료 옵션 제공에 도움을 줍니다. 이와 함께 종이 기반 기록, 처방전, 치료 계획의 오류를 줄이기 위해 블록체인과 인공지능(AI)을 통합하는 등 기술 발전도 시장 성장을 촉진하는 요인으로 작용하고 있습니다. 또한 각국 정부는 원격 암 정보 시스템을 도입하기 위해 연구개발(R&D) 부문에 많은 자금을 투입하고 있습니다. 이를 통해 의료진은 환자 곁에 있지 않더라도 모바일 애플리케이션을 통해 암의 장기적인 모니터링을 할 수 있게 됩니다. 그 결과, 특히 현재 진행 중인 신종 코로나바이러스 감염증(COVID-19) 및 이에 따른 강제 폐쇄 기간 중 의료 분야 전반에 걸쳐 도입이 가속화되고 있습니다. 이 밖에도 암 모니터링 시스템의 활용 가능성에 대한 소비자의 인식이 높아지고, 면역요법 및 방사선 치료시 OIS의 도입이 확대되는 등의 요인으로 인해 시장 전망이 밝아지고 있습니다.
목차
제1장 서문
제2장 조사 범위와 조사 방법
제3장 개요
제4장 서론
제5장 세계의 종양학 정보 시스템 시장
제6장 시장 내역 : 제품·서비스별
제7장 시장 내역 : 용도별
제8장 시장 내역 : 최종사용자별
제9장 시장 내역 : 지역별
제10장 SWOT 분석
제11장 밸류체인 분석
제12장 Porter's Five Forces 분석
제13장 가격 분석
제14장 경쟁 구도
KSA 26.04.30The global oncology information systems market size reached USD 4.4 Billion in 2025. Looking forward, IMARC Group expects the market to reach USD 7.4 Billion by 2034, exhibiting a growth rate (CAGR) of 5.71% during 2026-2034.
Oncology information systems (OIS) refers to a comprehensive information and image management solution that is designed for diagnosing, optimizing patient profile, and identifying suitable therapy for cancer to improve survival rate. They involve screening, prevention, analysis, treatment, and palliative care. As compared to conventional techniques, oncology systems offer remote access, planned treatment, future prediction, and proper management of clinical and non-clinical acquired data. Apart from this, OIS assists in keeping track of diagnostic details and treatment patterns, on account of which they are extensively employed in clinics, laboratories, hospitals, and research centers.
ONCOLOGY INFORMATION SYSTEMS MARKET TRENDS:
The oncology information systems market is majorly being driven by the increasing prevalence of cancer, especially amongst the rising geriatric population, due to the rising consumption of tobacco-based products and evolving lifestyles. OIS maintains electronic health records (EHR), which further assists in improving patient-based services, generating new insights into disease mechanism, detecting the early spread of the disease, and providing better treatment options. In line with this, significant technological advancements, such as the integration of blockchain and artificial intelligence (AI) to mitigate the errors of paper-based record creation, prescriptions, and treatment plans, is acting as another growth-inducing factor. Additionally, governments of various countries are extensively funding in the research and development (R&D) departments to introduce remote oncology information systems, which enables healthcare practitioners to perform long-term monitoring of cancer through mobile applications, without being physically present with the patient. This, in turn, has intensified their adoption across the healthcare sector, particularly during the ongoing coronavirus disease (COVID-19) and the consequent implementation of mandatory lockdowns. Other factors, such as growing consumer awareness regarding the availability of cancer monitoring systems and the escalating uptake of OIS to perform immunotherapy and radiation therapy, are creating a positive outlook for the market.
KEY MARKET SEGMENTATION:
Breakup by Product and Services:
- Software
- Patient Information Systems
- Treatment Planning Systems
- Services
- Consulting Services
- Implementation Services
- Maintenance Services
Breakup by Application:
- Radiation Oncology
- Medical Oncology
- Surgical Oncology
Breakup by End User:
- Hospitals and Diagnostic Imaging Centers
- Ablation Care Centers and Cancer Care Centers
- Government Institutions
- Research Facilities
Breakup by Region:
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Others
- Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
- Russia
- Others
- Latin America
- Brazil
- Mexico
- Others
- Middle East and Africa
Competitive Landscape:
The report provides a comprehensive analysis of the competitive landscape in the global oncology information systems market with detailed profiles of all major companies, including:
- Accuray Incorporated
- Advanced Data Systems
- CureMD
- Elekta
- EndoSoft
- Koninklijke Philips N.V
- McKesson Corporation
- MICA Information Systems, Inc.
- Oracle Corporation
- Varian (Siemens Healthineers Company)
KEY QUESTIONS ANSWERED IN THIS REPORT
1. What was the size of the global oncology information systems market in 2025?
2. What is the expected growth rate of the global oncology information systems market during 2026-2034?
3. What are the key factors driving the global oncology information systems market?
4. What has been the impact of COVID-19 on the global oncology information systems market?
5. What is the breakup of the global oncology information systems market based on the product and services?
6. What is the breakup of the global oncology information systems market based on the application?
7. What is the breakup of the global oncology information systems market based on the end user?
8. What are the key regions in the global oncology information systems market?
9. Who are the key players/companies in the global oncology information systems market?
Table of Contents
1 Preface
2 Scope and Methodology
- 2.1 Objectives of the Study
- 2.2 Stakeholders
- 2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
- 2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
- 2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
- 4.1 Overview
- 4.2 Key Industry Trends
5 Global Oncology Information Systems Market
- 5.1 Market Overview
- 5.2 Market Performance
- 5.3 Impact of COVID-19
- 5.4 Market Forecast
6 Market Breakup by Product and Services
- 6.1 Software
- 6.1.1 Market Trends
- 6.1.2 Key Segments
- 6.1.2.1 Patient Information Systems
- 6.1.2.2 Treatment Planning Systems
- 6.1.3 Market Forecast
- 6.2 Services
- 6.2.1 Market Trends
- 6.2.2 Key Segments
- 6.2.2.1 Consulting Services
- 6.2.2.2 Implementation Services
- 6.2.2.3 Maintenance Services
- 6.2.3 Market Forecast
7 Market Breakup by Application
- 7.1 Radiation Oncology
- 7.1.1 Market Trends
- 7.1.2 Market Forecast
- 7.2 Medical Oncology
- 7.2.1 Market Trends
- 7.2.2 Market Forecast
- 7.3 Surgical Oncology
- 7.3.1 Market Trends
- 7.3.2 Market Forecast
8 Market Breakup by End User
- 8.1 Hospitals and Diagnostic Imaging Centers
- 8.1.1 Market Trends
- 8.1.2 Market Forecast
- 8.2 Ablation Care Centers and Cancer Care Centers
- 8.2.1 Market Trends
- 8.2.2 Market Forecast
- 8.3 Government Institutions
- 8.3.1 Market Trends
- 8.3.2 Market Forecast
- 8.4 Research Facilities
- 8.4.1 Market Trends
- 8.4.2 Market Forecast
9 Market Breakup by Region
- 9.1 North America
- 9.1.1 United States
- 9.1.1.1 Market Trends
- 9.1.1.2 Market Forecast
- 9.1.2 Canada
- 9.1.2.1 Market Trends
- 9.1.2.2 Market Forecast
- 9.1.1 United States
- 9.2 Asia-Pacific
- 9.2.1 China
- 9.2.1.1 Market Trends
- 9.2.1.2 Market Forecast
- 9.2.2 Japan
- 9.2.2.1 Market Trends
- 9.2.2.2 Market Forecast
- 9.2.3 India
- 9.2.3.1 Market Trends
- 9.2.3.2 Market Forecast
- 9.2.4 South Korea
- 9.2.4.1 Market Trends
- 9.2.4.2 Market Forecast
- 9.2.5 Australia
- 9.2.5.1 Market Trends
- 9.2.5.2 Market Forecast
- 9.2.6 Indonesia
- 9.2.6.1 Market Trends
- 9.2.6.2 Market Forecast
- 9.2.7 Others
- 9.2.7.1 Market Trends
- 9.2.7.2 Market Forecast
- 9.2.1 China
- 9.3 Europe
- 9.3.1 Germany
- 9.3.1.1 Market Trends
- 9.3.1.2 Market Forecast
- 9.3.2 France
- 9.3.2.1 Market Trends
- 9.3.2.2 Market Forecast
- 9.3.3 United Kingdom
- 9.3.3.1 Market Trends
- 9.3.3.2 Market Forecast
- 9.3.4 Italy
- 9.3.4.1 Market Trends
- 9.3.4.2 Market Forecast
- 9.3.5 Spain
- 9.3.5.1 Market Trends
- 9.3.5.2 Market Forecast
- 9.3.6 Russia
- 9.3.6.1 Market Trends
- 9.3.6.2 Market Forecast
- 9.3.7 Others
- 9.3.7.1 Market Trends
- 9.3.7.2 Market Forecast
- 9.3.1 Germany
- 9.4 Latin America
- 9.4.1 Brazil
- 9.4.1.1 Market Trends
- 9.4.1.2 Market Forecast
- 9.4.2 Mexico
- 9.4.2.1 Market Trends
- 9.4.2.2 Market Forecast
- 9.4.3 Others
- 9.4.3.1 Market Trends
- 9.4.3.2 Market Forecast
- 9.4.1 Brazil
- 9.5 Middle East and Africa
- 9.5.1 Market Trends
- 9.5.2 Market Breakup by Country
- 9.5.3 Market Forecast
10 SWOT Analysis
- 10.1 Overview
- 10.2 Strengths
- 10.3 Weaknesses
- 10.4 Opportunities
- 10.5 Threats
11 Value Chain Analysis
12 Porters Five Forces Analysis
- 12.1 Overview
- 12.2 Bargaining Power of Buyers
- 12.3 Bargaining Power of Suppliers
- 12.4 Degree of Competition
- 12.5 Threat of New Entrants
- 12.6 Threat of Substitutes
13 Price Analysis
14 Competitive Landscape
- 14.1 Market Structure
- 14.2 Key Players
- 14.3 Profiles of Key Players
- 14.3.1 Accuray Incorporated
- 14.3.1.1 Company Overview
- 14.3.1.2 Product Portfolio
- 14.3.1.3 Financials
- 14.3.1.4 SWOT Analysis
- 14.3.2 Advanced Data Systems
- 14.3.2.1 Company Overview
- 14.3.2.2 Product Portfolio
- 14.3.3 CureMD
- 14.3.3.1 Company Overview
- 14.3.3.2 Product Portfolio
- 14.3.4 Elekta
- 14.3.4.1 Company Overview
- 14.3.4.2 Product Portfolio
- 14.3.4.3 Financials
- 14.3.4.4 SWOT Analysis
- 14.3.5 EndoSoft
- 14.3.5.1 Company Overview
- 14.3.5.2 Product Portfolio
- 14.3.6 Koninklijke Philips N.V.
- 14.3.6.1 Company Overview
- 14.3.6.2 Product Portfolio
- 14.3.6.3 Financials
- 14.3.6.4 SWOT Analysis
- 14.3.7 McKesson Corporation
- 14.3.7.1 Company Overview
- 14.3.7.2 Product Portfolio
- 14.3.7.3 Financials
- 14.3.7.4 SWOT Analysis
- 14.3.8 MICA Information Systems, Inc.
- 14.3.8.1 Company Overview
- 14.3.8.2 Product Portfolio
- 14.3.8.3 Financials
- 14.3.8.4 SWOT Analysis
- 14.3.9 Oracle Corporation
- 14.3.9.1 Company Overview
- 14.3.9.2 Product Portfolio
- 14.3.9.3 Financials
- 14.3.9.4 SWOT Analysis
- 14.3.10 Varian (Siemens Healthineers Company)
- 14.3.10.1 Company Overview
- 14.3.10.2 Product Portfolio
- 14.3.1 Accuray Incorporated
